BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angeli A, Ferraroni M, Supuran CT. Famotidine, an Antiulcer Agent, Strongly Inhibits Helicobacter pylori and Human Carbonic Anhydrases. ACS Med Chem Lett 2018;9:1035-8. [PMID: 30344913 DOI: 10.1021/acsmedchemlett.8b00334] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Das A, Rana S. The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19. Comput Biol Chem 2021;92:107482. [PMID: 33845430 DOI: 10.1016/j.compbiolchem.2021.107482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Supuran CT. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opin Drug Discov 2020;15:671-86. [PMID: 32208982 DOI: 10.1080/17460441.2020.1743676] [Cited by in Crossref: 25] [Cited by in F6Publishing: 41] [Article Influence: 12.5] [Reference Citation Analysis]
3 Del Prete S, Bua S, Supuran CT, Capasso C. Escherichia coli γ-carbonic anhydrase: characterisation and effects of simple aromatic/heterocyclic sulphonamide inhibitors. J Enzyme Inhib Med Chem 2020;35:1545-54. [PMID: 32746656 DOI: 10.1080/14756366.2020.1800670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
4 Del Prete S, De Luca V, Bua S, Nocentini A, Carginale V, Supuran CT, Capasso C. The Effect of Substituted Benzene-Sulfonamides and Clinically Licensed Drugs on the Catalytic Activity of CynT2, a Carbonic Anhydrase Crucial for Escherichia coli Life Cycle. Int J Mol Sci 2020;21:E4175. [PMID: 32545297 DOI: 10.3390/ijms21114175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
5 Campestre C, De Luca V, Carradori S, Grande R, Carginale V, Scaloni A, Supuran CT, Capasso C. Carbonic Anhydrases: New Perspectives on Protein Functional Role and Inhibition in Helicobacter pylori. Front Microbiol 2021;12:629163. [PMID: 33815311 DOI: 10.3389/fmicb.2021.629163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Angeli A, Tanini D, Nocentini A, Capperucci A, Ferraroni M, Gratteri P, Supuran CT. Selenols: a new class of carbonic anhydrase inhibitors. Chem Commun (Camb) 2019;55:648-51. [PMID: 30560259 DOI: 10.1039/c8cc08562e] [Cited by in Crossref: 33] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
7 Grande R, Perez Perez GI. Editorial: Keep Calm and Care for Your Microbiota: The Role of H. pylori and Microbiota in Gastric Diseases. Front Microbiol 2021;12:692472. [PMID: 34335519 DOI: 10.3389/fmicb.2021.692472] [Reference Citation Analysis]
8 Berrino E, Supuran CT. Novel approaches for designing drugs that interfere with pH regulation. Expert Opin Drug Discov 2019;14:231-48. [PMID: 30681011 DOI: 10.1080/17460441.2019.1567488] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
9 Angeli A, Pinteala M, Maier SS, Del Prete S, Capasso C, Simionescu BC, Supuran CT. Inhibition of α-, β-, γ-, δ-, ζ- and η-class carbonic anhydrases from bacteria, fungi, algae, diatoms and protozoans with famotidine. J Enzyme Inhib Med Chem 2019;34:644-50. [PMID: 30727781 DOI: 10.1080/14756366.2019.1571273] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
10 Sharonova T, Zhmurov P, Kalinin S, Nocentini A, Angeli A, Ferraroni M, Korsakov M, Supuran CT, Krasavin M. Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile. J Enzyme Inhib Med Chem 2022;37:857-65. [PMID: 35296197 DOI: 10.1080/14756366.2022.2051023] [Reference Citation Analysis]
11 Sharma V, Kumar R, Angeli A, Supuran CT, Sharma PK. Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes. European Journal of Medicinal Chemistry 2020;193:112219. [DOI: 10.1016/j.ejmech.2020.112219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Angeli A, Di Cesare Mannelli L, Ghelardini C, Peat TS, Bartolucci G, Menicatti M, Carta F, Supuran CT. Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects. Eur J Med Chem 2019;177:188-97. [PMID: 31136893 DOI: 10.1016/j.ejmech.2019.05.058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
13 Tanini D, Capperucci A, Ferraroni M, Carta F, Angeli A, Supuran CT. Direct and straightforward access to substituted alkyl selenols as novel carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry 2020;185:111811. [DOI: 10.1016/j.ejmech.2019.111811] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
14 Grande R, Carradori S, Puca V, Vitale I, Angeli A, Nocentini A, Bonardi A, Gratteri P, Lanuti P, Bologna G, Simeone P, Capasso C, De Luca V, Supuran CT. Selective Inhibition of Helicobacter pylori Carbonic Anhydrases by Carvacrol and Thymol Could Impair Biofilm Production and the Release of Outer Membrane Vesicles. Int J Mol Sci 2021;22:11583. [PMID: 34769015 DOI: 10.3390/ijms222111583] [Reference Citation Analysis]
15 Nocentini A, Supuran CT. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opinion on Drug Discovery 2019;14:1175-97. [DOI: 10.1080/17460441.2019.1651289] [Cited by in Crossref: 50] [Cited by in F6Publishing: 58] [Article Influence: 16.7] [Reference Citation Analysis]
16 Ghobadi E, Ghanbarimasir Z, Emami S. A review on the structures and biological activities of anti-Helicobacter pylori agents. Eur J Med Chem 2021;223:113669. [PMID: 34218084 DOI: 10.1016/j.ejmech.2021.113669] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Angeli A, Ferraroni M, Nocentini A, Selleri S, Gratteri P, Supuran CT, Carta F. Polypharmacology of epacadostat: a potent and selective inhibitor of the tumor associated carbonic anhydrases IX and XII. Chem Commun (Camb) 2019;55:5720-3. [PMID: 31038135 DOI: 10.1039/c8cc09568j] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
18 Del Prete S, Angeli A, Ghobril C, Hitce J, Clavaud C, Marat X, Supuran CT, Capasso C. Sulfonamide Inhibition Profile of the β-Carbonic Anhydrase from Malassezia restricta, An Opportunistic Pathogen Triggering Scalp Conditions. Metabolites 2020;10:E39. [PMID: 31963335 DOI: 10.3390/metabo10010039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
19 Angeli A, Pinteala M, Maier SS, Simionescu BC, Da'dara AA, Skelly PJ, Supuran CT. Sulfonamide Inhibition Studies of an α-Carbonic Anhydrase from Schistosoma mansoni, a Platyhelminth Parasite Responsible for Schistosomiasis. Int J Mol Sci 2020;21:E1842. [PMID: 32155992 DOI: 10.3390/ijms21051842] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Camadan Y, Çiçek B, Adem Ş, Çalişir Ü, Akkemik E. Investigation of in vitro and in silico effects of some novel carbazole Schiff bases on human carbonic anhydrase isoforms I and II. J Biomol Struct Dyn 2021;:1-10. [PMID: 33645441 DOI: 10.1080/07391102.2021.1892527] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Çalışır Ü, Camadan Y, Çiçek B, Akkemik E, Eyüpoğlu V, Adem Ş. Synthesis, characterizations of aryl-substituted dithiodibenzothioate derivatives, and investigating their anti-Alzheimer's properties. J Biomol Struct Dyn 2022;:1-18. [PMID: 35021953 DOI: 10.1080/07391102.2021.2024884] [Reference Citation Analysis]
22 Angeli A, Kartsev V, Petrou A, Pinteala M, Vydzhak RM, Panchishin SY, Brovarets V, De Luca V, Capasso C, Geronikaki A, Supuran CT. New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase Inhibitors. Pharmaceuticals (Basel) 2021;14:828. [PMID: 34451924 DOI: 10.3390/ph14080828] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ali M, Bozdag M, Farooq U, Angeli A, Carta F, Berto P, Zanotti G, Supuran CT. Benzylaminoethyureido-Tailed Benzenesulfonamides: Design, Synthesis, Kinetic and X-ray Investigations on Human Carbonic Anhydrases. Int J Mol Sci 2020;21:E2560. [PMID: 32272689 DOI: 10.3390/ijms21072560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]